Search - tctmd.com

Displaying 181 - 200 of 220

Sort: Relevancy | Date

News Conference News EuroPCR 2013

PRAGUE-19 Registry: Bioresorbable Scaffolds an Option for Certain STEMI Patients

Caitlin E. Cox

May 22, 2013

News Daily News

Prasugrel Noninferior to Ticagrelor in STEMI, but Both Require Hours to Achieve Effect

Yael L. Maxwell

May 13, 2013

News Daily News

Stroke After STEMI Unusual But Carries Poor Prognosis

Yael L. Maxwell

May 03, 2013

News Daily News

La Bivalirudina Mejora a la Heprina en la Reducción del Riesgo Hemorrágico tras la CAS

L.A. McKeown

April 26, 2013

News Daily News

Bivalirudin Bests Heparin for Lowering Bleeding Risk After CAS

L.A. McKeown

April 26, 2013

News Conference News ACC 2013

DEFER-STEMI: Holding Off Stenting for Several Hours Improves Outcomes

L.A. McKeown

March 08, 2013

News Daily News

Early Discharge Safe for Many STEMI Patients After Primary PCI

Jason Kahn

February 21, 2013

News Daily News

TROFI Published: No Clear Benefit of Thrombectomy in STEMI Patients Undergoing PCI

L.A. McKeown

February 12, 2013

Presentation TCT 2013

Risk Stratification and Outcomes of Patients with Prior Coronary Artery Stenting Undergoing Noncardiac Surgery

Presenter: Andrew Goodman, Michael Chenier, Kyle Hornsby, Lindsay Anderson, Brett Goodwin, Kamil Faridi, Chee Tang Chin, Tracy Wang

January 31, 2013

News Daily News

APPOSITION II Published: Self-Expanding Stent Performs Well in STEMI Patients

December 17, 2012

News Conference News TCT 2012

Biomarkers May Identify Risky Subcritical Lesions

October 30, 2012

News Daily News

Danish Study Looks at Impact of Socioeconomic Status on Primary PCI Outcomes

Caitlin E. Cox

October 09, 2012

News Daily News

Timing of Platelet Testing Key to Optimal Therapy After PCI for ACS

L.A. McKeown

August 20, 2012

News Daily News

La programación de pruebas de plaqueta es fundamental para la estrategia de clopidogrel después de una ICP por ACS

L.A. McKeown

August 20, 2012

Presentation

Initial and Chronic Response to Clopidogrel After Stenting for ACS and Influence on Clinical Outcomes

Presenter: Thomas Cuisset

August 17, 2012

News Daily News

Meta-analysis: PCI Beats Medical Therapy for Angina Relief but Little Else in Stable CAD

Jason Kahn

August 14, 2012

News Daily News

Xience V Noninferior to Cypher for Primary PCI

July 24, 2012

News Daily News

HORIZONS-AMI: Similar Outcomes with Abciximab, Eptifibatide During Primary PCI

July 05, 2012

News Daily News

La Opción Antitrombótica durante una PCI Influye en los Resultados de los Malos Respondedores al Clopidogrel

Caitlin E. Cox

June 07, 2012

News Daily News

Antithrombotic Choice During PCI Influences Outcomes in Poor Clopidogrel Responders

Caitlin E. Cox

June 07, 2012

Advertisement

PRAGUE-19 Registry: Bioresorbable Scaffolds an Option for Certain STEMI Patients

Prasugrel Noninferior to Ticagrelor in STEMI, but Both Require Hours to Achieve Effect

Stroke After STEMI Unusual But Carries Poor Prognosis

La Bivalirudina Mejora a la Heprina en la Reducción del Riesgo Hemorrágico tras la CAS

Bivalirudin Bests Heparin for Lowering Bleeding Risk After CAS

DEFER-STEMI: Holding Off Stenting for Several Hours Improves Outcomes

Early Discharge Safe for Many STEMI Patients After Primary PCI

TROFI Published: No Clear Benefit of Thrombectomy in STEMI Patients Undergoing PCI

Risk Stratification and Outcomes of Patients with Prior Coronary Artery Stenting Undergoing Noncardiac Surgery

APPOSITION II Published: Self-Expanding Stent Performs Well in STEMI Patients

Biomarkers May Identify Risky Subcritical Lesions

Danish Study Looks at Impact of Socioeconomic Status on Primary PCI Outcomes

Timing of Platelet Testing Key to Optimal Therapy After PCI for ACS

La programación de pruebas de plaqueta es fundamental para la estrategia de clopidogrel después de una ICP por ACS

Initial and Chronic Response to Clopidogrel After Stenting for ACS and Influence on Clinical Outcomes

Meta-analysis: PCI Beats Medical Therapy for Angina Relief but Little Else in Stable CAD

Xience V Noninferior to Cypher for Primary PCI

HORIZONS-AMI: Similar Outcomes with Abciximab, Eptifibatide During Primary PCI

La Opción Antitrombótica durante una PCI Influye en los Resultados de los Malos Respondedores al Clopidogrel

Antithrombotic Choice During PCI Influences Outcomes in Poor Clopidogrel Responders

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content